Adenocarcinoma of the Pancreas Withdrawn Phase 1 / 2 Trials for Fluorouracil (DB00544)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

DBCOND0029532 (Adenocarcinoma of the Pancreas)Withdrawn1 / 2 IdentifierTitlePurposeDrugs
NCT02575508Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerTreatment